Rahimian M, Jafari-Gharabaghlou D, Mohammadi E, Zarghami N
Phage (New Rochelle). 2025; 5(4):203-222.
PMID: 40045937
PMC: 11876824.
DOI: 10.1089/phage.2024.0011.
Kim M, Suh G, Cullen G, Perez Rodriguez S, Dharmaraj T, Chang T
J Clin Invest. 2025; 135(5).
PMID: 40026251
PMC: 11870740.
DOI: 10.1172/JCI187996.
Fu Y, Yin M, Cao L, Lu Y, Li Y, Zhang L
Commun Biol. 2025; 8(1):257.
PMID: 39966630
PMC: 11836320.
DOI: 10.1038/s42003-025-07687-8.
Papudeshi B, Roach M, Mallawaarachchi V, Bouras G, Grigson S, Giles S
Bioinform Adv. 2025; 5(1):vbaf004.
PMID: 39897948
PMC: 11783317.
DOI: 10.1093/bioadv/vbaf004.
Supina B, McCutcheon J, Peskett S, Stothard P, Dennis J
mBio. 2025; 16(3):e0281424.
PMID: 39868782
PMC: 11898562.
DOI: 10.1128/mbio.02814-24.
Sxt1, Isolated from a Therapeutic Phage Cocktail, Is a Broader Host Range Relative of the Phage T3.
Iarema P, Kotovskaya O, Skutel M, Drobiazko A, Moiseenko A, Sokolova O
Viruses. 2025; 16(12.
PMID: 39772213
PMC: 11680406.
DOI: 10.3390/v16121905.
Phage-mediated virulence loss and antimicrobial susceptibility in carbapenem-resistant .
Yu Y, Wang M, Ju L, Li M, Zhao M, Deng H
mBio. 2024; 16(2):e0295724.
PMID: 39714187
PMC: 11796411.
DOI: 10.1128/mbio.02957-24.
Genome-wide identification of bacterial genes contributing to nucleus-forming jumbo phage infection.
Harding K, Malone L, Kyte N, Jackson S, Smith L, Fineran P
Nucleic Acids Res. 2024; 53(3).
PMID: 39694477
PMC: 11797060.
DOI: 10.1093/nar/gkae1194.
A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections.
Kim M, Chen Q, Echterhof A, Pennetzdorfer N, McBride R, Banaei N
Nat Commun. 2024; 15(1):9987.
PMID: 39609398
PMC: 11604943.
DOI: 10.1038/s41467-024-53994-9.
phage therapy candidates from Sphae: An automated toolkit for predicting sequencing data.
Papudeshi B, Roach M, Mallawaarachchi V, Bouras G, Grigson S, Giles S
bioRxiv. 2024; .
PMID: 39605506
PMC: 11601643.
DOI: 10.1101/2024.11.18.624194.
Strategies for the biocontrol Pseudomonas infections pre-fruit harvest.
Warring S, Sisson H, Fineran P, Rabiey M
Microb Biotechnol. 2024; 17(10):e70017.
PMID: 39364588
PMC: 11450377.
DOI: 10.1111/1751-7915.70017.
Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs.
Kunisch F, Campobasso C, Wagemans J, Yildirim S, Chan B, Schaudinn C
Nat Commun. 2024; 15(1):8572.
PMID: 39362854
PMC: 11450229.
DOI: 10.1038/s41467-024-52595-w.
Challenges and opportunities of phage therapy for infections.
Kou X, Yang X, Zheng R
Appl Environ Microbiol. 2024; 90(10):e0135324.
PMID: 39345202
PMC: 11497816.
DOI: 10.1128/aem.01353-24.
DeepPBI-KG: a deep learning method for the prediction of phage-bacteria interactions based on key genes.
Wei T, Lu C, Du H, Yang Q, Qi X, Liu Y
Brief Bioinform. 2024; 25(6).
PMID: 39344712
PMC: 11440089.
DOI: 10.1093/bib/bbae484.
Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant .
Choi Y, Kim S, Shin M, Kim J
Antibiotics (Basel). 2024; 13(7).
PMID: 39061292
PMC: 11273472.
DOI: 10.3390/antibiotics13070610.
The role of rhizosphere phages in soil health.
Wang X, Tang Y, Yue X, Wang S, Yang K, Xu Y
FEMS Microbiol Ecol. 2024; 100(5).
PMID: 38678007
PMC: 11065364.
DOI: 10.1093/femsec/fiae052.
Large-scale genomic survey with deep learning-based method reveals strain-level phage specificity determinants.
Yang Y, Dufault-Thompson K, Yan W, Cai T, Xie L, Jiang X
Gigascience. 2024; 13.
PMID: 38649301
PMC: 11034027.
DOI: 10.1093/gigascience/giae017.
The virtue of training: extending phage host spectra against vancomycin-resistant strains using the Appelmans method.
Lossouarn J, Beurrier E, Bouteau A, Moncaut E, Sir Silmane M, Portalier H
Antimicrob Agents Chemother. 2024; 68(5):e0143923.
PMID: 38591854
PMC: 11210271.
DOI: 10.1128/aac.01439-23.
Predictive phage therapy for urinary tract infections: Cocktail selection for therapy based on machine learning models.
Keith M, Park de la Torriente A, Chalka A, Vallejo-Trujillo A, McAteer S, Paterson G
Proc Natl Acad Sci U S A. 2024; 121(12):e2313574121.
PMID: 38478693
PMC: 10962980.
DOI: 10.1073/pnas.2313574121.
Collateral sensitivity increases the efficacy of a rationally designed bacteriophage combination to control .
Acton L, Pye H, Thilliez G, Kolenda R, Matthews M, Turner A
J Virol. 2024; 98(3):e0147623.
PMID: 38376991
PMC: 10949491.
DOI: 10.1128/jvi.01476-23.